Navigation and Content
You are in  Saudi Arabia
or Select a different country

DELIVERING NEXT LEVEL HEALTHCARE Direct-to-X services: diverse, fast, and agile #WeCare

Direct-to-X services enable patient-centric care models by delivering all categories of treatments, products, and clinical kits to an increasingly varied range of patient, consumer, and end-user locations.

Our global logistics infrastructure enables pharmaceutical, medical device, clinical trials, and consumer health organizations to develop segmented supply chains with a range of Direct-to-X models which are diverse, fast, and agile.


With more than 20 years’ experience serving the life science & healthcare industry and even longer for other industries with long-established direct distribution models, DHL has the expertise, capability, and global infrastructure to design, implement, operate, and improve all aspects of your direct-to-X supply chain. 

White Glove services with direct delivery to healthcare settings

Bespoke White Glove services with real time tracking and same day delivery to all healthcare provider locations

Home pickup & delivery of Clinical Trial shipments

Increased access to Clinical Trials with on-time, compliant home delivery and pickup of clinical materials and samples

Medical Devices direct delivery to hospitals

Managing device final mile operations and providing spare parts to installation & maintenance crews 

International same day and time definite shipments

High service level international B2B and B2C shipments for direct to market and point of use deliveries

eCommerce fulfilment network for home delivery

For consumer, pharmaceutical and medical devices products, DHL's global network of e-fulfilment centers ensure high standards and low costs

Omni channel fulfilment centers

Reach customers and consumers with integrated solutions servicing multiple delivery channels & modes 


DHL has an established suite of products and solutions fulfilling the needs of all sectors within the life sciences & healthcare industry, whether bypassing wholesalers or delivering directly to doorstep. 

Case Studies


89% of Clinical Trial sponsors use technology to enable a decentralized model with direct to participant deliveries

wider variety of end-user settings.

Consumer trends create demand for new, patient-centric value chains in healthcare, capable of delivering drugs and medical devices to a much wider variety of end-user settings.


Direct-to-Patient (DTP) market is projected to grow at a CAGR of 6.1% until 2032

Take Your Direct-to-X Services To The Next Level

Our latest report, ‘Delivering Next-Level Healthcare’ provides expert analysis on the technological, social and economic trends fueling the current healthcare revolution. Learn all about the logistics and supply chain innovations that are now crucial to the future of healthcare.